U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768800) titled 'Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic Product' on Aug. 12.
Brief Summary: This is a single-center, single-blind clinical study designed to evaluate the dermatological safety of a cosmetic product and to demonstrate the absence of comedogenic and acnegenic potential.
A total of 33 female participants, aged 18 to 60 years, with oily and acne-prone skin will be enrolled. Participants will use the investigational product for 28 days under normal conditions of use.
Dermatological safety, skin tolerability, and the absence of comedogenic and acnegenic effects will be assessed throughout...